IRCT20170930036486N2RecruitingPhase 3
Comparison between the efficacy of topical product of Sambucus ebulus and Hydrocortisone on the clinical severity of patients with hand eczema
Conditions
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Enrollment
- 72
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •Age 18 to 60 years
- •Patients with hands eczema who have not received any topical medication from the 14 days prior to study
Exclusion Criteria
- •Pregnant mothers
- •Nursing mothers
- •The presence of underlying diseases of the kidney, liver, heart, diabetes,
- •History of drug allergy
- •Patients with obsessive-compulsive disorder or other mental illness that interferes with the study
- •Use of Systemic Corticosteroids or Immunosupressives over the past 4 weeks
- •Localized infection in the place of eczema
Investigators
Similar Trials
Not yet recruiting
Phase 2
Evaluation of the effectiveness of topical product containing henna and turmeric with Persian medicine based formulation in patients with contact dermatitis. Triple-blind clinical trialIrritant contact dermatitiscontact dermatitis.IRCT20220321054336N1Tehran University of Medical Sciences33
Recruiting
Not Applicable
The evaluation of effectiveness of a topical formulation of linseed oil in patients with knee osteoarthritisIRCT2017082011341N9Vice chancellor for research,Fasa University of Medical Sciences94
Not yet recruiting
Not Applicable
Curcumin vs retinoic acid topical application in treatment of oralpremalignant lesionsCTRI/2022/12/048473Sri Rajiv Gandhi College of dental Sciences and hospital
Recruiting
Phase 3
Effectiveness of topical application of zinc oxide 25% versus zinc oxide 25% plus breastmilk on diaper dermatitisDiaper dermatitisIRCT20220630055329N1Tehran University of Medical Sciences42
Completed
Not Applicable
Effect of combined topical solution 2% salicylic acid and erythromycin 4% with erythromycin 4% topical solution in the treatment of mild to moderate acne vulgarisMild to modrate acne vulgaris.Acne vulgarisIRCT201010094269N3Deputy of Tabriz University of Medical Sciences and Health Services50